Clinical Trial Update: Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a three-drug combination of interferon gamma, pegylated interferon alpha-2a, and ribavirin in chronic hepatitis C patients who…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon-gamma (interferon gamma)
• Peg-Interferon Alpha-2a (pegylated interferon alpha-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED